Other Events
Other Events and Activities
-
Multiexon COL1A2 deletion as a rare mechanism in osteogenesis imperfecta: Case report and literature review
Oliveira D, Almeida PM, Franco S, et al. Multiexon COL1A2 deletion as a rare mechanism in osteogenesis imperfecta: Case report and literature review. Bone. Published online January 29, 2026. doi:10.1016/j.bone.2026.117810
-
Diagnosis, treatment, and management recommendations for cleidocranial dysplasia: A Modified Delphi panel
Hoover-Fong J, Anderson-Cermin C, Artinian F, et al. Diagnosis, treatment, and management recommendations for cleidocranial dysplasia: A Modified Delphi panel. J Bone Miner Res. Published online January 8, 2026. Doi:10.1093/jbmr/zjag004
-
Six at Sixty. Commentary on osteogenesis imperfecta 1975–2025
Sillence D. Six at Sixty. Commentary on osteogenesis imperfecta 1975-2025. J Med Genet. 2025;62(6):422-426. Published 2025 May 27. Doi:10.1136/jmg-2025-110807
-
Watch for It: TransCon® hGH Enhances TransCon® CNP Benefits in Achondroplasia (Week 26 COACH Trial)
Watch for peer-reviewed paper on TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial
-
Watch for It: BridgeBio Reports First Significant Body Proportionality Improvements in Achondroplasia Trial
Watch for peer-reviewed paper on BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
-
Join Us for the 17th International Skeletal Dysplasia Society Meeting
Toronto, Ontario, Canada | August 26–29, 2026 | The Hospital for Sick Children (SickKids)
-
Call for Abstracts
17th International Skeletal Dysplasia Society Meeting (ISDS2026)